Abstract
5014 Background: Results from a global phase 3 study demonstrated that orteronel 400 mg BID /prednisone 5 mg (O+P), vs placebo/prednisone alone (P), improved radiographic progression (rPFS) and inc...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
